Mutations in the ccr5 gene
domain of the human acetyltransferase p300 could activate can prevent the virus from infecting a cell leading to a highly
gene expression at specific sites [123]. Moreover, fusion of resistant but otherwise healthy phenotype. In fact, altering
dCas9 to the KRAB repressor was able to induce methylation the wild-type ccr5 gene leads to immunity of monocytes and
at specific enhancers leading to reduced chromatin accessibility macrophages against HIV infections [132-134].
and, thus, silencing of gene expression [124]. Precise epigen- The CRISPR-Cas9 technique has further simplified
ome editing has great potential to reveal site-specific genome-scale screens. These screens seek to identify genes
chromatin modification and helps to explore the regulation of that are involved in certain metabolic or pathogenetic processes
gene expression that could lead to new therapeutical strategies. by abolishing gene function and studying the resulting pheno-
Other approaches—mainly in prokaryotes—exploit the type.